NIOX Group (NIOX) Competitors

GBX 62.40 -0.60 (-0.95%)

As of 06:52 AM Eastern

NIOX vs. EKF, CREO, IUG, NCYT, and IHC

Should you buy NIOX Group stock or one of its competitors? MarketBeat compares NIOX Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NIOX Group include EKF Diagnostics (EKF), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), and Inspiration Healthcare Group (IHC). These companies are all part of the "medical devices" industry.

How does NIOX Group compare to EKF Diagnostics?

EKF Diagnostics (LON:EKF) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

In the previous week, NIOX Group had 1 more articles in the media than EKF Diagnostics. MarketBeat recorded 2 mentions for NIOX Group and 1 mentions for EKF Diagnostics. EKF Diagnostics' average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
EKF Diagnostics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NIOX Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NIOX Group has lower revenue, but higher earnings than EKF Diagnostics. NIOX Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EKF Diagnostics	£51.56M	2.27	£4.68M	£0.47	57.96
NIOX Group	£48.70M	5.39	£995.88M	£1.64	38.05

EKF Diagnostics presently has a consensus price target of GBX 35, suggesting a potential upside of 28.47%. NIOX Group has a consensus price target of GBX 86, suggesting a potential upside of 37.82%. Given NIOX Group's higher possible upside, analysts clearly believe NIOX Group is more favorable than EKF Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

22.6% of EKF Diagnostics shares are owned by institutional investors. Comparatively, 17.4% of NIOX Group shares are owned by institutional investors. 39.7% of EKF Diagnostics shares are owned by insiders. Comparatively, 4.9% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

EKF Diagnostics has a beta of 0.491, indicating that its share price is 51% less volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

NIOX Group has a net margin of 14.37% compared to EKF Diagnostics' net margin of 4.12%. NIOX Group's return on equity of 10.14% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EKF Diagnostics	4.12%	3.01%	5.27%
NIOX Group	14.37%	10.14%	3.95%

Summary

NIOX Group beats EKF Diagnostics on 8 of the 13 factors compared between the two stocks.

How does NIOX Group compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and NIOX Group (LON:NIOX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, NIOX Group had 1 more articles in the media than Creo Medical Group. MarketBeat recorded 2 mentions for NIOX Group and 1 mentions for Creo Medical Group. Creo Medical Group's average media sentiment score of 0.00 equaled NIOX Group'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Creo Medical Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
NIOX Group	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NIOX Group has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Creo Medical Group	£4.60M	10.60	-£25.04M	-£1.00	N/A
NIOX Group	£48.70M	5.39	£995.88M	£1.64	38.05

NIOX Group has a consensus price target of GBX 86, suggesting a potential upside of 37.82%. Given NIOX Group's stronger consensus rating and higher probable upside, analysts plainly believe NIOX Group is more favorable than Creo Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Creo Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

45.2% of Creo Medical Group shares are owned by institutional investors. Comparatively, 17.4% of NIOX Group shares are owned by institutional investors. 4.1% of Creo Medical Group shares are owned by insiders. Comparatively, 4.9% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Creo Medical Group has a beta of 1.498894, suggesting that its stock price is 50% more volatile than the broader market. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market.

Creo Medical Group has a net margin of 768.18% compared to NIOX Group's net margin of 14.37%. Creo Medical Group's return on equity of 32.72% beat NIOX Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Creo Medical Group	768.18%	32.72%	-20.09%
NIOX Group	14.37%	10.14%	3.95%

Summary

NIOX Group beats Creo Medical Group on 10 of the 15 factors compared between the two stocks.

How does NIOX Group compare to Intelligent Ultrasound Group?

NIOX Group (LON:NIOX) and Intelligent Ultrasound Group (LON:IUG) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

NIOX Group presently has a consensus price target of GBX 86, suggesting a potential upside of 37.82%. Given NIOX Group's stronger consensus rating and higher possible upside, analysts plainly believe NIOX Group is more favorable than Intelligent Ultrasound Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Intelligent Ultrasound Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

NIOX Group has a net margin of 14.37% compared to Intelligent Ultrasound Group's net margin of -23.11%. NIOX Group's return on equity of 10.14% beat Intelligent Ultrasound Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	14.37%	10.14%	3.95%
Intelligent Ultrasound Group	-23.11%	-23.58%	-13.51%

17.4% of NIOX Group shares are owned by institutional investors. Comparatively, 75.5% of Intelligent Ultrasound Group shares are owned by institutional investors. 4.9% of NIOX Group shares are owned by company insiders. Comparatively, 12.8% of Intelligent Ultrasound Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, NIOX Group had 2 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 2 mentions for NIOX Group and 0 mentions for Intelligent Ultrasound Group. NIOX Group's average media sentiment score of 0.00 equaled Intelligent Ultrasound Group'saverage media sentiment score.

Company	Overall Sentiment
NIOX Group	Neutral
Intelligent Ultrasound Group	Neutral

NIOX Group has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£48.70M	5.39	£995.88M	£1.64	38.05
Intelligent Ultrasound Group	£6.57M	0.00	-£2.27M	-£0.68	N/A

NIOX Group has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Intelligent Ultrasound Group has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

Summary

NIOX Group beats Intelligent Ultrasound Group on 12 of the 14 factors compared between the two stocks.

How does NIOX Group compare to Novacyt?

NIOX Group (LON:NIOX) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Novacyt	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

NIOX Group has a net margin of 14.37% compared to Novacyt's net margin of -135.96%. NIOX Group's return on equity of 10.14% beat Novacyt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	14.37%	10.14%	3.95%
Novacyt	-135.96%	-111.34%	-27.98%

17.4% of NIOX Group shares are owned by institutional investors. Comparatively, 10.7% of Novacyt shares are owned by institutional investors. 4.9% of NIOX Group shares are owned by company insiders. Comparatively, 0.5% of Novacyt shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, NIOX Group had 2 more articles in the media than Novacyt. MarketBeat recorded 2 mentions for NIOX Group and 0 mentions for Novacyt. Novacyt's average media sentiment score of 0.76 beat NIOX Group's score of 0.00 indicating that Novacyt is being referred to more favorably in the news media.

Company	Overall Sentiment
NIOX Group	Neutral
Novacyt	Positive

NIOX Group has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£48.70M	5.39	£995.88M	£1.64	38.05
Novacyt	£20.03M	1.66	-£36.80M	-£43.00	N/A

NIOX Group has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Novacyt has a beta of 0.973, suggesting that its share price is 3% less volatile than the broader market.

Summary

NIOX Group beats Novacyt on 14 of the 16 factors compared between the two stocks.

How does NIOX Group compare to Inspiration Healthcare Group?

NIOX Group (LON:NIOX) and Inspiration Healthcare Group (LON:IHC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

NIOX Group has a net margin of 14.37% compared to Inspiration Healthcare Group's net margin of -25.32%. NIOX Group's return on equity of 10.14% beat Inspiration Healthcare Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	14.37%	10.14%	3.95%
Inspiration Healthcare Group	-25.32%	-69.35%	-3.47%

NIOX Group presently has a consensus price target of GBX 86, suggesting a potential upside of 37.82%. Given NIOX Group's stronger consensus rating and higher possible upside, equities analysts plainly believe NIOX Group is more favorable than Inspiration Healthcare Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inspiration Healthcare Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, NIOX Group had 2 more articles in the media than Inspiration Healthcare Group. MarketBeat recorded 2 mentions for NIOX Group and 0 mentions for Inspiration Healthcare Group. NIOX Group's average media sentiment score of 0.00 equaled Inspiration Healthcare Group'saverage media sentiment score.

Company	Overall Sentiment
NIOX Group	Neutral
Inspiration Healthcare Group	Neutral

17.4% of NIOX Group shares are owned by institutional investors. Comparatively, 8.2% of Inspiration Healthcare Group shares are owned by institutional investors. 4.9% of NIOX Group shares are owned by company insiders. Comparatively, 8.4% of Inspiration Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Inspiration Healthcare Group has a beta of 0.717, suggesting that its stock price is 28% less volatile than the broader market.

NIOX Group has higher revenue and earnings than Inspiration Healthcare Group. Inspiration Healthcare Group is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£48.70M	5.39	£995.88M	£1.64	38.05
Inspiration Healthcare Group	£45.20M	0.60	-£12.20M	-£13.65	N/A

Summary

NIOX Group beats Inspiration Healthcare Group on 14 of the 15 factors compared between the two stocks.

Get NIOX Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NIOX vs. The Competition

Export

Metric	NIOX Group	Medical Devices Industry	Medical Sector	LON Exchange
Market Cap	£262.34M	£2.07B	£6.30B	£2.79B
Dividend Yield	2.46%	2.67%	2.79%	6.09%
P/E Ratio	38.05	14.02	21.03	366.06
Price / Sales	5.39	133.68	554.66	88,425.13
Price / Cash	11.21	15.99	42.94	27.89
Price / Book	3.46	4.63	9.78	7.66
Net Income	£995.88M	£144.75M	£3.55B	£5.89B
7 Day Performance	-2.80%	-0.56%	-0.52%	0.46%
1 Month Performance	9.47%	2.85%	1.21%	2.48%
1 Year Performance	-10.86%	8.06%	41.26%	87.67%

NIOX Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NIOX NIOX Group	2.0132 of 5 stars	GBX 62.40 -1.0%	GBX 86 +37.8%	-5.9%	£262.34M	£48.70M	38.05	92
EKF EKF Diagnostics	1.8596 of 5 stars	GBX 25 -4.9%	GBX 35 +40.0%	+33.8%	£107.63M	£51.56M	53.19	356	Gap Down
CREO Creo Medical Group	N/A	GBX 12.55 -1.6%	N/A	+16.0%	£51.77M	£4.60M	N/A	279
IUG Intelligent Ultrasound Group	N/A	N/A	N/A	N/A	£42.76M	£6.57M	N/A	65
NCYT Novacyt	N/A	GBX 46.70 +10.4%	N/A	+31.7%	£33.84M	£19.45M	N/A	120	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:NIOX) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NIOX Group (NIOX) Competitors

NIOX vs. EKF, CREO, IUG, NCYT, and IHC

How does NIOX Group compare to EKF Diagnostics?

Summary

How does NIOX Group compare to Creo Medical Group?

Summary

How does NIOX Group compare to Intelligent Ultrasound Group?

Summary

How does NIOX Group compare to Novacyt?

Summary

How does NIOX Group compare to Inspiration Healthcare Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NIOX vs. The Competition

NIOX Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NIOX Group (NIOX) Competitors

NIOX vs. EKF, CREO, IUG, NCYT, and IHC

How does NIOX Group compare to EKF Diagnostics?

Does the media favor EKF or NIOX?

Which has higher earnings & valuation, EKF or NIOX?

Do analysts rate EKF or NIOX?

Do insiders & institutionals hold more shares of EKF or NIOX?

Which has more risk & volatility, EKF or NIOX?

Is EKF or NIOX more profitable?

Summary

How does NIOX Group compare to Creo Medical Group?

Does the media favor CREO or NIOX?

Which has stronger earnings and valuation, CREO or NIOX?

Do analysts recommend CREO or NIOX?

Do institutionals & insiders hold more shares of CREO or NIOX?

Which has more volatility and risk, CREO or NIOX?

Is CREO or NIOX more profitable?

Summary

How does NIOX Group compare to Intelligent Ultrasound Group?

Do analysts recommend NIOX or IUG?

Is NIOX or IUG more profitable?

Do insiders and institutionals hold more shares of NIOX or IUG?

Does the media refer more to NIOX or IUG?

Which has higher earnings & valuation, NIOX or IUG?

Which has more risk and volatility, NIOX or IUG?

Summary

How does NIOX Group compare to Novacyt?

Do analysts recommend NIOX or NCYT?

Is NIOX or NCYT more profitable?

Do insiders and institutionals hold more shares of NIOX or NCYT?

Does the media refer more to NIOX or NCYT?

Which has higher earnings & valuation, NIOX or NCYT?

Which has more risk and volatility, NIOX or NCYT?

Summary

How does NIOX Group compare to Inspiration Healthcare Group?

Is NIOX or IHC more profitable?

Do analysts recommend NIOX or IHC?

Does the media refer more to NIOX or IHC?

Do institutionals and insiders hold more shares of NIOX or IHC?

Which has more risk & volatility, NIOX or IHC?

Which has better valuation and earnings, NIOX or IHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NIOX vs. The Competition

NIOX Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools